Fikreyesus Mahlet, Soboka Matiwos, Feyissa Garumma Tolu
Amanuel Mental Health Specialized Hospital, Addis Ababa, Ethiopia.
Department of Psychiatry, Jimma University, Jimma, Ethiopia.
BMC Psychiatry. 2016 Oct 20;16(1):354. doi: 10.1186/s12888-016-1076-2.
Psychotic relapse leads to repeated hospitalization and negatively affects the clinical prognosis of the patients. Information on prevalence of relapse among patients with psychotic disorders in Ethiopian setting is scarce. This study aimed to assess the prevalence of relapse among patients with psychotic disorders attending services in Jimma University Specialized Hospital (JUSH).
Data were collected using interviewer administered questionnaire. We used medication adherence rating scale (MARS) to assess compliance to medication and abnormal involuntary movement scale (AIMS) to detect medication side effects. Logistic regression analysis was used to identify independent predictors of psychotic relapse. All variables with P-value <0.25 in the bivariate analyses were entered into multivariate logistic regression and variables with P-value < 0.05 in the final model were declared to be significantly associated with the outcome variable.
The prevalence of relapse among patients with psychotic disorder was 24.6 % (n = 95). Of this, 25.4 and 22.4 % were males and females respectively. The odds of developing psychotic relapse among patients living with family was 72 % lower than that of patients living alone (aOR = 0.28, 95 % CI = 0.08, 0.93). The odds of developing psychotic relapse among patients compliant to medication was 69 % lower than that of patients who were not compliant to medications (aOR = 0.31, 95 % CI = 0.12, 0.80). The odds of developing psychotic relapse among patients having high score on social support score was 48 % lower than that of patients who were compliant to medications (aOR = 0.52, 95 % CI = 0.28, 0.95). The odds of developing psychotic relapse among patients reporting to have sought religious support was 45 % lower than that of patients who have not sought religious support (aOR = 0.55, 95 % CI = 0.31, 0.96). On the other hand, the odds of developing psychotic relapse among participants who have experienced medication side effects was 1.83 times higher when compared to those who have never experienced medication side effects (aOR = 1.83, 95 % CI = 1.01, 3.31).
The high prevalence of relapse among patients with psychotic disorder needs special attention. Clinicians need to pay attention to medication side effects the patient faces. Intervening noncompliance to medication and appropriately managing medication side effects may help in preventing psychotic relapse that may result because of non-compliance. The provision of counseling, psycho education, psycho social support may help patients in improving compliance to medication and reducing psychotic relapse. Developing and strengthening community based rehabilitation services should be emphasized as part of mental healthcare services.
精神病性复发会导致反复住院,并对患者的临床预后产生负面影响。埃塞俄比亚环境下精神病性障碍患者复发率的信息匮乏。本研究旨在评估在吉姆马大学专科医院(JUSH)就诊的精神病性障碍患者的复发率。
使用访谈员管理的问卷收集数据。我们使用药物依从性评定量表(MARS)评估药物依从性,并使用异常不自主运动量表(AIMS)检测药物副作用。采用逻辑回归分析确定精神病性复发的独立预测因素。在双变量分析中P值<0.25的所有变量都纳入多变量逻辑回归,最终模型中P值<0.05的变量被宣布与结果变量显著相关。
精神病性障碍患者的复发率为24.6%(n = 95)。其中,男性和女性的复发率分别为25.4%和22.4%。与独居患者相比,与家人同住的患者发生精神病性复发的几率低72%(调整后比值比[aOR]=0.28,95%置信区间[CI]=0.08,0.93)。依从药物治疗的患者发生精神病性复发的几率比不依从药物治疗的患者低69%(aOR = 0.31,95% CI = 0.12,0.80)。社会支持得分高的患者发生精神病性复发的几率比依从药物治疗的患者低48%(aOR = 0.52,95% CI = 0.28,0.95)。报告寻求宗教支持的患者发生精神病性复发的几率比未寻求宗教支持的患者低45%(aOR = 0.55,95% CI = 0.31,0.96)。另一方面,与从未经历过药物副作用的参与者相比,经历过药物副作用的参与者发生精神病性复发的几率高1.83倍(aOR = 1.83,95% CI = 1.01,3.31)。
精神病性障碍患者的高复发率需要特别关注。临床医生需要关注患者面临的药物副作用。干预药物不依从并适当管理药物副作用可能有助于预防因不依从导致的精神病性复发。提供咨询、心理教育、心理社会支持可能有助于患者提高药物依从性并减少精神病性复发。应强调发展和加强基于社区的康复服务,作为精神卫生保健服务的一部分。